Cell Biotech Co. Ltd (049960) — Capital Reinvestment Ratio
Cell Biotech Co. Ltd (049960) has a Capital Reinvestment Ratio of 0.55x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩4.15 Billion) in capital expenditures (₩2.29 Billion). Check Cell Biotech Co. Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cell Biotech Co. Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Cell Biotech Co. Ltd's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see 049960 cash flow metrics.
Annual Capital Reinvestment Ratio for Cell Biotech Co. Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Cell Biotech Co. Ltd from 2011 to 2024. See free cash flow generation of Cell Biotech Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | ₩19.27 Billion | ₩1.28 Billion | ▼ -69.2% |
| 2023 | 0.22x | ₩7.82 Billion | ₩1.69 Billion | ▲ +3.4% |
| 2022 | 0.21x | ₩12.81 Billion | ₩2.67 Billion | ▲ +266.0% |
| 2021 | 0.06x | ₩14.89 Billion | ₩848.59 Million | ▼ -82.3% |
| 2020 | 0.32x | ₩9.56 Billion | ₩3.08 Billion | ▼ -65.2% |
| 2019 | 0.93x | ₩10.23 Billion | ₩9.47 Billion | ▲ +81.9% |
| 2018 | 0.51x | ₩13.98 Billion | ₩7.11 Billion | ▲ +114.0% |
| 2017 | 0.24x | ₩22.53 Billion | ₩5.36 Billion | ▲ +98.3% |
| 2016 | 0.12x | ₩17.99 Billion | ₩2.16 Billion | ▼ -35.4% |
| 2015 | 0.19x | ₩18.24 Billion | ₩3.38 Billion | ▲ +32.8% |
| 2014 | 0.14x | ₩9.91 Billion | ₩1.38 Billion | ▼ -80.1% |
| 2013 | 0.70x | ₩8.99 Billion | ₩6.31 Billion | ▲ +29.0% |
| 2012 | 0.54x | ₩6.17 Billion | ₩3.36 Billion | ▲ +411.4% |
| 2011 | 0.11x | ₩5.45 Billion | ₩580.85 Million | — |